Flexion Therapeutics (FLXN) to Offer $75M in Common Stock

Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced that it has commenced an underwritten public offering of $75,000,000 of shares of its common stock. Flexion also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. All of the shares in the offering will be sold by Flexion. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Goldman Sachs & Co. LLC and Credit Suisse are acting as joint book-running managers for the proposed offering.

You May Also Be Interested In

• YZi Labs ends proxy fight with CEA Industries in board deal
• CME Group CEO Terry Duffy to step down in 2027, CFO to succeed